Publication: Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
…
Description
56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA
Keywords
Citation
WoS Q
Scopus Q
Source
Volume
124
Issue
21